- Home
- VRDN vs ADEA Comparison
VRDN vs ADEA Comparison
Compare VRDN & ADEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- ADEA
- Stock Information
- Founded
- VRDN 2006
- ADEA 1990
- Country
- VRDN United States
- ADEA United States
- Employees
- VRDN N/A
- ADEA N/A
- Industry
- VRDN Medical Specialities
- ADEA Computer Software: Prepackaged Software
- Sector
- VRDN Health Care
- ADEA Technology
- Exchange
- VRDN Nasdaq
- ADEA Nasdaq
- Market Cap
- VRDN 1.5B
- ADEA 1.6B
- IPO Year
- VRDN N/A
- ADEA N/A
- Fundamental
- Price
- VRDN $18.87
- ADEA $15.65
- Analyst Decision
- VRDN Strong Buy
- ADEA Strong Buy
- Analyst Count
- VRDN 11
- ADEA 4
- Target Price
- VRDN $38.80
- ADEA $19.50
- AVG Volume (30 Days)
- VRDN 877.5K
- ADEA 481.2K
- Earning Date
- VRDN 11-11-2025
- ADEA 11-06-2025
- Dividend Yield
- VRDN N/A
- ADEA 1.28%
- EPS Growth
- VRDN N/A
- ADEA 80.44
- EPS
- VRDN N/A
- ADEA 0.74
- Revenue
- VRDN $305,000.00
- ADEA $378,674,000.00
- Revenue This Year
- VRDN N/A
- ADEA $9.49
- Revenue Next Year
- VRDN $35,092.81
- ADEA $4.94
- P/E Ratio
- VRDN N/A
- ADEA $21.16
- Revenue Growth
- VRDN 5.90
- ADEA 5.47
- 52 Week Low
- VRDN $9.90
- ADEA $10.59
- 52 Week High
- VRDN $27.20
- ADEA $17.46
- Technical
- Relative Strength Index (RSI)
- VRDN 52.46
- ADEA 61.46
- Support Level
- VRDN $18.12
- ADEA $15.09
- Resistance Level
- VRDN $20.51
- ADEA $15.62
- Average True Range (ATR)
- VRDN 0.94
- ADEA 0.39
- MACD
- VRDN -0.01
- ADEA -0.02
- Stochastic Oscillator
- VRDN 34.66
- ADEA 86.41
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About ADEA Adeia Inc.
Adeia Inc is a consumer and entertainment product/solutions licensing company. Its only operating segment being Intellectual Property (IP) Licensing. In the IP segment, the company licenses innovations to companies in the broader entertainment industry, and those developing new technologies that will help drive this industry forward. It includes Pay-TV, Consumer Electronics, Connected Car, and Media Platform.